Molecular Approaches to Diagnosis of Cancer

  • P. Thomas


Many cancers can be controlled with existing methods of therapy provided that they are treated early enough. These cancers include the major killers, cancers of the lung, breast and gastrointestinal tract. For example, while no significant change has occurred in death rates from colorectal cancer over the last 50 years, the American Cancer Society has estimated that early diagnosis and prompt treatment could save a majority of the 50 000 Americans who die annually of the disease. Methods for early detection of cancers are therefore of great benefit to the patient and, while not providing a cure in themselves, make the patient more curable.


Acid Phosphatase Epithelial Ovarian Cancer Human Chorionic Gonadotropin Molecular Approach Prostatic Acid Phosphatase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bagshawe, K.D. (1983) Tumour markers — Where do we go from here? Br. J. Cancer, 48, 167–75CrossRefGoogle Scholar
  2. 2.
    Harris, C.C., Yolken, R.A. & Hsu, I.-H. (1982) Enzyme immunoassays: applications in cancer research. In H. Busch & L.C. Yeoman (eds) Methods in Cancer Research, vol. 20, Academic Press, New York, pp. 213–43Google Scholar
  3. 3.
    Primus, F.J. & Goldenberg, D.M. (1982) Functional histopathology of cancer: a review of immunoenzyme histochemistry. In H. Bush & L.C. Yeoman (eds) Methods in Cancer Research, vol. 20, Academic Press, New York, pp. 139–82Google Scholar
  4. 4.
    Hunter, W.M. (1973) Radioimmunoassay. In D.M. Weir (ed.) Handbook of Experimental Immunology, Blackwell Scientific Publications, London, pp. 2–36Google Scholar
  5. 5.
    Zamcheck, N. (1981) The expanding field of colorectal cancer markers: CEA the prototype. Cancer Bull., 33, 141–51Google Scholar
  6. 6.
    Thomas, P. & Zamcheck, N. (1983) Role of the liver in clearance of excretion of circulating carcinoembryonic antigen (CEA). Dig. Dis. Sci., 28, 216–24CrossRefGoogle Scholar
  7. 7.
    Thomas, P., Toth, C.A., Byrn, R.A., Saravis, C.A., Loewenstein, M.S. (1983) Five patients with markedly elevated CEA blood levels and impaired clearance of circulating CEA. Clin. Res., 31, 696AGoogle Scholar
  8. 8.
    Gelder, F.B., Reese, C.J., Moossa, A.R., Hall, T. & Hunter, R. (1978) Purification, partial characterization and clinical evaluation of a pancreatic oncofetal antigen. Cancer Res., 38, 313–24Google Scholar
  9. 9.
    Haagensen, D.E. (1981) Biochemical relationship between gross cystic disease and breast carcinoma. In C.D. Haagensen, C. Bodian & D.E. Haagensen (eds) Breast Carcinoma Risk and Detection, W.B. Saunders, Philadelphia, pp. 300–38Google Scholar
  10. 10.
    Bast, R.C., Klug, T.L., St John, E., Jenison, E., Niloff, J.M., Lazarus, H., Berkowitz, R.S., Leavitt, T., Griffiths, C.T., Parker, L., Zurawski, V.R. & Knapp, R.C. (1983) A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med., 309, 883–7CrossRefGoogle Scholar
  11. 11.
    Choe, B.-K. & Rose, N.R. (1982) Prostatic acid phosphatase: a marker for human prostatic adenocarcinoma. In H. Busch & L.D. Yeoman (eds) Methods in Cancer Research, vol. 19, Academic Press, New York, pp. 199–232Google Scholar
  12. 12.
    Balinksy, D. (1980) Enzymes and isoenzymes in cancer. In S. Sell (ed.) Cancer Markers, Humana Press, Clifton, NJ, pp. 191–224Google Scholar
  13. 13.
    Soloman, A. (1980) Monoclonal immunoglobulins as biomarkers of cancer. In S. Sell (ed.) Cancer Markers, Humana Press, Clifton, NJ, pp. 57–87CrossRefGoogle Scholar
  14. 14.
    Marcus, D.M. & Zinberg, N. (1975) Measurement of serum ferritin by radioimmunoassay, results in normal individuals and patients with breast cancer. J. Natl. Cancer Inst., 55, 791–5Google Scholar
  15. 15.
    Cooper, E.H. & Stone, J. (1970) Acute phase reactant proteins in cancer. Adv. Cancer Res., 30, 1–44CrossRefGoogle Scholar
  16. 16.
    Holyoke, D. & Chu, T.M. (1979) Tissue polypeptide antigen. In R.B. Herberman & K.R. Mclntire (eds) Immunodiagnosis of Cancer, Marcel Dekker, New York, pp. 513–21Google Scholar
  17. 17.
    Blackstock, R. & Humphrey, G.B. (1982) Surface marker in the characterization of leukemias. In H. Busch & L.D. Yeoman (eds) Methods in Cancer Research, vol. 19, Academic Press, New York, pp. 3–51Google Scholar
  18. 18.
    Goldenberg, D.M, Deland, F. & Kim, E. (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N. Engl. J. Med., 298, 1384–8CrossRefGoogle Scholar

Copyright information

© Peter B. Farmer and John M. Walker 1985

Authors and Affiliations

  • P. Thomas

There are no affiliations available

Personalised recommendations